Yesterday the Supreme Court took a half step forward toward some sense of proportion in patent law—and they took a half step backwards. Today, in a unanimous decision, the court ruled that human genes cannot be patented. At the same time, they ruled that complementary DNA (cDNA) could be patented. This case against Myriad Genetics, Inc. asked the court to … Continue reading




